Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline E Muller

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Psychiatry Reports|August 16, 2005
Anxiety and medical disordersJacqueline E Muller, Liezl Koen, Dan J Stein
CNS Drugs|May 24, 2005
Social anxiety disorder : current treatment recommendationsJacqueline E Muller, Liezl Koen, Soraya Seedat, et al.
The Journal of Clinical Psychiatry|November 24, 2004
The social anxiety disorder spectrumDan J Stein, Yutaka Ono, Osamu Tajima, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 8, 2008
Depression and anxiety in multisomatoform disorder: prevalence and clinical predictors in primary careJacqueline E Muller, Ignatius Wentzel, Daniel G Nel, et al.
Current Psychiatry Reports|July 21, 2004
Anxiety disorders and schizophreniaJacqueline E Muller, Liezl Koen, Seedat Soraya, et al.
BMC Psychiatry|October 31, 2006
Morphological features in a Xhosa schizophrenia populationLiezl Koen, Dana J H Niehaus, Greetje De Jong, et al.
International Clinical Psychopharmacology|August 16, 2003
Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot studySoraya Seedat, Eugene van Rheede van Oudtshoorn, Jacqueline E Muller, et al.
International Clinical Psychopharmacology|December 20, 2007
Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trialJacqueline E Muller, Ignatius Wentzel, Liezl Koen, et al.
BMC Psychiatry|January 26, 2005
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]Paul D Carey, Bavanisha Vythilingum, Soraya Seedat, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Psychiatry Reports|August 16, 2005
Anxiety and medical disordersJacqueline E Muller, Liezl Koen, Dan J Stein
CNS Drugs|May 24, 2005
Social anxiety disorder : current treatment recommendationsJacqueline E Muller, Liezl Koen, Soraya Seedat, et al.
The Journal of Clinical Psychiatry|November 24, 2004
The social anxiety disorder spectrumDan J Stein, Yutaka Ono, Osamu Tajima, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 8, 2008
Depression and anxiety in multisomatoform disorder: prevalence and clinical predictors in primary careJacqueline E Muller, Ignatius Wentzel, Daniel G Nel, et al.
Current Psychiatry Reports|July 21, 2004
Anxiety disorders and schizophreniaJacqueline E Muller, Liezl Koen, Seedat Soraya, et al.
BMC Psychiatry|October 31, 2006
Morphological features in a Xhosa schizophrenia populationLiezl Koen, Dana J H Niehaus, Greetje De Jong, et al.
International Clinical Psychopharmacology|August 16, 2003
Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot studySoraya Seedat, Eugene van Rheede van Oudtshoorn, Jacqueline E Muller, et al.
International Clinical Psychopharmacology|December 20, 2007
Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trialJacqueline E Muller, Ignatius Wentzel, Liezl Koen, et al.
BMC Psychiatry|January 26, 2005
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]Paul D Carey, Bavanisha Vythilingum, Soraya Seedat, et al.
Pageof 1